DAIC

JULY 18, 2024

The announcement from the company, based in Canadian and founded in 2007, offered that Akyuz is joining Circle during a period of accelerated growth and product innovation. Earlier this year, Circle launched its next generation platform, cvi42 6.1,

Cardiovascular Imaging 105

Cardiovascular Imaging Innovation Technology Hospital 105

DAIC

APRIL 23, 2024

milla1cf Tue, 04/23/2024 - 15:53 April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. Eur J Cardiothorac Surg 2022 Aug 3;62(3) 10 Klautz RJM, Rao V, Reardon MJ, et al. 5 Verbelen T, Roussel JC, Cathenis K, et al.,

Aortic valve 111

Aortic valve Aortic Innovation Cardiothoracic 111

DAIC

JUNE 13, 2024

Getty Images milla1cf Thu, 06/13/2024 - 20:38 June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. Eur J Cardiothorac Surg 2022 Aug 3;62(3) 10 Klautz RJM, Rao V, Reardon MJ, et al. August 2022;62(3):ezac374.

Aortic valve 109

Aortic valve Aortic Innovation Cardiothoracic 109

DAIC

MAY 14, 2024

We’re excited to collaborate with Medis Medical Imaging to add innovative, non-invasive, image-based QFR to our portfolio of offerings around our Allia IGS platform to streamline the experience for clinicians and help us to deliver on our vision for the future image-guided therapy.” Leon, Shubin Qiao, Gregg W.

Coronary Artery Disease 111

Coronary Artery Disease Interventional Cardiology Innovation Physiology 111

DAIC

JANUARY 15, 2024

Ultromics' expertise has been demonstrated through its algorithms for improving the detection of Heart Failure, which previously received FDA Breakthrough Device Designation before being cleared by the FDA in November 2022. For more information: [link] References: 1 Maurer M, Elliott P, Comenzo R, et al.

Ultrasound 119

Ultrasound Coronary Artery Disease Innovation Heart Failure 119

DAIC

JANUARY 24, 2025

In September 2022, the Food and Drug Administration (FDA) granted abelacimab Fast Track status for the prevention of stroke and systemic embolism in patients with AFib, recognizing the unmet need and the potential benefits of abelacimab. Curr Cardiol Rep. Rahman F et al. Nat Rev Cardiol. Colilla S et al.Am Hsu J et al JAMA Cardiol.

AFIB 52

AFIB Atrial Fibrillation General Cardiology Stroke 52

DAIC

JUNE 20, 2024

Increased control and efficiency with automated workflows The Philips Zenition Image-Guided Therapy Mobile C-arm Systems bring together innovations in image capture and processing, ease-of-use, and versatility, many of which were pioneered on Philips’ highly successful image guided therapy platform Azurion.

Anatomy 105

Anatomy Innovation Technology Outcomes 105

DAIC

DECEMBER 11, 2023

million EUR in 2022. Since its inception in 2015, Biomodex has invested over 12 million EUR in IP and R&D, leading to the development of several innovative products and technology advances which will be very synergistic to Mentice’s current portfolio. The global Biomodex business reached a total turnover of 2.2

Anatomy 105

Anatomy Innovation Technology 105

DAIC

APRIL 1, 2024

“The concepts I wrote in this paper also form the crux of what we are doing here at the Center for Innovation at Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. Is There Medication for Valvular Heart Disease?

Technology 105

Technology Heart Disease Innovation Ultrasound 105

DAIC

FEBRUARY 7, 2024

This new document builds off of the previously published Best Practices for Consumer Cardiovascular Technology Solutions in January 2022. Cardiovascular disease is the leading cause of death globally, taking an estimated 695,000 lives in 2021 in the United States, about 1 in every 5 deaths, according to the CDC.

Technology 116

Technology Cardiovascular Disease Best Practices AFIB 116

CardiacWire

MAY 18, 2024

Overall healthcare AI clearances are gaining momentum, with 2023 bringing a 42% jump in clearances, more than doubling 2022 and 2021’s annual growth (+20% & +16%). in 2020-2022, and 13.5% FFRCT, coronary plaque, etc). since the start of 2023. Cardiovascular AI applications also appear to be getting more diverse.

Cardiovascular Imaging 69

Cardiovascular Imaging Plaque Innovation Ablation 69

DAIC

JANUARY 3, 2024

With improved clinical accuracy compared to existing traditional Holter monitoring 6,7 , we look forward to introducing our innovative technology to many more patients in Europe.” iRhythm Technologies, 2022. Global Burden of Cardiovascular Diseases and Risks, 1990-2022. Data on file. iRhythm Technologies, 2023. Hannun, AY.

Technology 98

Technology Certification Arrhythmia Electrocardiogram 98

DAIC

APRIL 3, 2024

This leap in early detection marks both a significant medical innovation and a new era in the detection of cardiovascular disease. doi: 10.1136/bmjhci-2022-100718 FDA 510(k) Summary, K233409 Bachtiger, P., For the first time, U.S. In the U.S., BMJ Health & Care Informatics, 30:e100718.

Heart Failure 111

Heart Failure Cardiomyopathy AFIB Hospital 111

Frontiers in Cardiovascular Medicine

JANUARY 10, 2024

Aim This study aims to perform a bibliometric review of research on congenital heart disease in the Arab world from 1997 to 2022. Most of the published research was clinical, with limited innovative contributions and a preference for regional journals.

Congenital Heart Disease 59

Congenital Heart Disease Congenital Research Heart Disease 59

DAIC

MAY 6, 2024

We are committed to protecting the future commercial value of our innovative PH-HFpEF treatment,” said Chris Giordano , President & Chief Executive Officer of Tenax Therapeutics. Getty Images milla1cf Mon, 05/06/2024 - 10:48 May 6, 2024 — Tenax Therapeutics, Inc. ,

Preserved Ejection Fraction 105

Preserved Ejection Fraction Heart Failure Pulmonary Hypertension 105

CardiacWire

AUGUST 9, 2024

Cardiovascular AI applications continued to largely analyze imaging and ECG data, although imaging+ECG’s share of cardio AI clearances fell to 74% in H1 2024 (down from 83% in 2023 and 88% in 2022) due to a recent increase in EHR and sensor-based cardio AI products.

Innovation 52

Innovation TAVR Cardiovascular Imaging Plaque 52

Frontiers in Cardiovascular Medicine

JULY 11, 2024

Frequent keywords with average publication time after 2019 mainly included arrhythmogenic cardiomyopathy, whole-exome sequencing, RBM 20, phenotype, risk stratification, precision medicine, genotype, and machine learning.ConclusionThe research landscape of genetics in DCM is continuously evolving.

Cardiomyopathy 52

Cardiomyopathy Research Sudden Cardiac Death Document 52

DAIC

MARCH 31, 2025

These findings challenge the long-held assumption that frequent symptoms justify short-duration monitoring, said Mintu Turakhia, MD, iRhythm Chief Medical and Scientific Officer and EVP of Product Innovation. Published March 24, 2022. Treasure Island (FL): StatPearls Publishing; June 5, 2023. Arrhythmias - What Is an Arrhythmia?

Arrhythmia 52

Arrhythmia Atrial Fibrillation Tachycardia Heart Failure 52

DAIC

JUNE 7, 2024

We believe the intentional and innovative design of the Evolut TAV platform enables the excellent and consistent clinical evidence demonstrated in randomized clinical trials. The quality of our design and the valve performance set Evolut apart from other TAVs in the market.” iii Am Heart Assoc. 2021;10:e018816. DOI: 10.1161/JAHA.120.018816.

TAVR 111

TAVR Aortic valve Aortic Stenosis 111

Society of Thoracic Surgeons - Technology

JANUARY 19, 2022

This fellowship also will allow Dr. Fiedler and Dr. Folesani to learn novel techniques, adapt innovative technology, and receive training from expert mentors who are dedicated to the highest standards of cardiothoracic surgery. Folesani to attend STS 2023 in San Diego, and Dr. Fiedler to attend EACTS 2022 in Milan.

Cardiothoracic 52

Cardiothoracic Heart Transplant Allied Health Education 52

DAIC

FEBRUARY 12, 2024

In November, 2022, the company launched its new Barostim NEO2 IPG. CVRx is a commercial-stage medical device company focused on the developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases.

Heart Failure 104

Heart Failure Hospital Quality of Life Heart Attack 104

Circulation: Cardiovascular Quality & Outcomes

FEBRUARY 3, 2025

A notable gap in the literature concerns the role of modern approaches to cardiovascular device innovation in shaping and perpetuating health disparities.

Health Disparities 40

Health Disparities Interventional Cardiology Innovation Cardiovascular Disease 40

Cardiomatics

JUNE 6, 2024

As a result, innovative service providers are growing rapidly by leveraging integrated remote monitoring solutions to provide ECGs via extensive pharmacy networks. Italy is pioneering a push for telemedicine and home care in cardiology with the application of groundbreaking new regulation that took effect in January 2024.

COVID-19 98

COVID-19 Hospital Outpatient Innovation 98

Circulation: Cardiovascular Quality & Outcomes

MARCH 26, 2025

We analyzed the data using thematic analysis to identify common themes related to enrollment and engagement.RESULTS:Between July and August 2022, we performed 20 patient interviews and 6 provider interviews. Most patient participants were male (n=12) and identified their race and ethnicity as White (n=15).

Hypertension 40

Hypertension Blood Pressure Chronic Disease Innovation 40

Stroke Journal

FEBRUARY 1, 2024

in the 'Homeward Stroke Recovery Discharge Rate' from Fiscal Year 2022 to Fiscal Year 2023 (rising from 43.9% in the 'Homeward Stroke Recovery Discharge Rate' from Fiscal Year 2022 to Fiscal Year 2023 (rising from 43.9% The observed 5.6%

Strokes 40

Strokes Stroke Certification Academic 40

Stroke Journal

FEBRUARY 1, 2024

The median DTN time was 40 minutes in 2020, 39 in 2021, 38 in 2022 and 36 in year-to-date 2023. in 2022, to 88.6% Stroke, Volume 55, Issue Suppl_1 , Page ATP117-ATP117, February 1, 2024. Introduction:Reducing door-to-needle (DTN) times lead to improved patient outcomes in acute ischemic stroke. in 2020, to 31.9% in 2021, to 59.6%

Thrombolysis 40

Thrombolysis Academic Document Innovation 40

Cassling

SEPTEMBER 8, 2023

Alongside quantifiable factors such as salary and benefits, hospital size, patient volume, and work schedule, qualitative factors like innovation also come into play. And you can't talk about innovation without technology. How Technology Fits In 2022, the consulting company Gallup asked 13,085 U.S.

Radiologic Technologist 52

Radiologic Technologist Technology Soft Skills Article 52

Stroke Journal

JANUARY 30, 2025

This study evaluates whether these innovations have led to significant reductions in treatment times and length of stay (LOS) in a single center.Methods:We conducted a single-center, retrospective analysis comparing acute ischemic stroke and TIA patients across three periods: pre-Pulsara (January 1, 2013July 31, 2018; n=96), post-Pulsara/pre-Viz (August (..)

Strokes 40

Strokes Stroke Outcomes Technology 40

Wellnest

JANUARY 24, 2024

This innovative technique not only provides functional heart valves for neonates but also offers the promise of lifelong solutions, transforming the landscape of pediatric heart surgeries. Challenges and Opportunities: While the success of partial heart transplants is evident, challenges persist, primarily centered around organ availability.

Heart Transplant 52

Heart Transplant Transplant Pediatrics Congenital 52

DAIC

FEBRUARY 13, 2024

Previous to GWU, Earls served as Medical Director and Vice President at Fairfax Radiological Consultants (FRC) in Fairfax, VA, where he was an early innovator and clinical adopter of coronary CT angiography. AJR Am J Roentgenol 2022 Sep;219(3):407-419. 7 Bär S, Nabeta T, Maaniitty T.

Coronary Artery Disease 103

Coronary Artery Disease Ischemia Atherosclerosis Cardiovascular Imaging 103

Society of Thoracic Surgeons - Technology

MARCH 2, 2022

Blog Introducing New Technology to an Institution jbagley Wed, 03/02/2022 - 11:15 Innovation and new technology are essential to the progress of any specialty. Van Haren, MD, MsPH Career Development Blog Early Career Technology March 2, 2022 Robert M. Van Haren, MD, MsPH Image 3 min read

Technology 52

Technology Blog Cardiothoracic Outcomes 52

Dr. S. Venkatesan MD

JULY 1, 2024

The innovators and engineers of new-age mechanical assist systems could learn a few crucial insights from these unique and humble animal beings. Epub 2022 Jul 25. If the ventricles assume a tubular morphology, optimal energy and cardiac power can be accrued. Batisda procedure etc) 3. Aalkjær C, Wang T. J Muscle Res Cell Motil.

Cardiomyopathy 52

Cardiomyopathy Aortic valve Aortic Blood Pressure 52

DAIC

MAY 21, 2024

The study is the largest and most robust of its kind to date, examining 102,475 Hello Heart users with high BP (hypertension) between January 2018 and December 2022. Founded in 2013, Hello Heart is a digital leader in preventive heart health and a member of the American Heart Association’s Innovators’ Network.

Blood Pressure 52

Blood Pressure Cholesterol Risk Factors BMI 52

Open Heart

JANUARY 17, 2024

It also has the potential to foster innovation and reduce duplication through data and materials sharing. We then extracted the corresponding author’s name and email from all articles published in these journals between 1 March 2021 and 1 March 2022. This is a publicly available portal that draws from Scopus.

Research 40

Research Article Innovation 40

Stroke Journal

JANUARY 30, 2025

We collected administrative and chart review data for all neurology consults. 4 process measures were defined a priori: antithrombotic (AT) medication, high or medium potency statin, anticoagulation for atrial fibrillation (AF), and dual antiplatelet therapy (DAPT) 90 days or less after the consult completion.

Outpatient 40

Outpatient Strokes Stroke Atrial Fibrillation 40

Dr. S. Venkatesan MD

APRIL 10, 2024

The innovative double balloon catheter Inflation across the the mechanical prosthetic valve is possible. David Smith, Ayush Khurana, Aprim Youhana, Adrian Ionescu, Kissing Balloon “Valvuloplasty” of Obstructed Mechanical Aortic Valve: When You Are Running Out of Options, JACC: Case Reports,Volume 4, Issue 13, 2022, Pages 799-801, 2.Kandzari

Aortic valve 52

Aortic valve Aortic Thrombosis Bicuspid/Mitral 52

Dr. S. Venkatesan MD

SEPTEMBER 23, 2024

ORBITA-1 was an excellent and Innovative trial, that answered the above query without any doubt , that PCI has no add on value over medical therapy in chronic CAD. What we really wanted to know for a long time , was whether PCI really beats medical therapy in stable angina of moderate or severe intensity with at least one critical lesion.

Angina 52

Angina Academic Stenosis Article 52